1
![NuPathe]()
![NuPathe]()
![NuPathe]()
NuPathe
Leadership team
Terri Sebree (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Malvern, Pennsylvania, United States
Established
2005
Company Registration
SEC CIK number: 0001734722
Traded as
NASDAQ:PATH
Overview
Location
Summary
NuPathe is a pharmaceutical company that creates pharmaceutical therapies and treatments.
History
NuPathe was founded in 2006 to develop products and therapies to treat a variety of neurological conditions, particularly those with a high unmet medical need. NuPathe has continued to develop new products and therapies to address a variety of complex conditions.
Mission
NuPathe’s mission is to develop safe, effective, and innovative treatments for neurological conditions with a focus on providing a personalized care experience and improving the lives of those we serve.
Vision
Our vision is to be a global leader in neurology, developing and delivering the most advanced treatments to patients and families impacted by neurological conditions.
Key Team
Terri Sebree (Founder)
Recognition and Awards
NuPathe has won numerous awards, including the World Premiere Award in Global Health from the American Academy of Neurology and the Breakthrough Products of the Year award from the Scientists' Choice Awards.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Terri Sebree (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Malvern, Pennsylvania, United States
Established
2005
Company Registration
SEC CIK number: 0001734722
Traded as
NASDAQ:PATH